Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Urinary Tract Infection
Studies show Pathnostics UTI test required fewer resources, reduced costs compared to standard testing
In the study, the average one-year costs related to UTIs were $501.85 lower for patients receiving treatment based on the Guidance test than for those receiving treatment based on the traditional culture test.
June 20, 2023
OpGen signs distribution agreement with Fisher Healthcare, submits FDA de novo request
Under the distribution agreement, Fisher Healthcare will have access to the Unyvero A50 platform and products to distribute and sell to hospitals and laboratories across the U.S.
April 19, 2023
Electronic health record interventions reduce unnecessary urine culture orders, study finds
According to the study, electronic health record interventions can significantly reduce unnecessary urine culture orders, resulting in cost savings and improved patient care.
March 2, 2023
OpGen to prepare FDA de novo request, completes clinical trial for UTI panel
The completed trial evaluated the performance of the Unyvero UTI Panel for detecting urinary tract infections using clean-catch or catheter-related urine samples.
December 13, 2022
GoMeyra expands information management system to include panels for monkeypox, UTIs, STIs
The GoMeyra Laboratory Information Management Systems platform now processes tests for monkeypox, UTIs, and STIs. Respiratory and toxicology tests are in the planning stages.
September 29, 2022
Improving kidney stone analysis, treatment with AI
Kidney stones are common, affecting more than 1 in 10 people, and these hard deposits made of minerals and salts can lead to severe pain, urinary tract infections, and loss of kidney function if they are left untreated.
July 25, 2022
Vela launches new PCR test for detecting urinary tract infection
The test, called PathoKey MP UTI ID and AMR PCR, is currently for research use only, the company said. It allows for the in vitro detection and categorization of 14 pathogens that cause urinary tract infections and 14 antimicrobial resistance genes that block five antibiotics.
May 18, 2022
Page 1 of 1
